Manufactures and sells branded personal care products in India, with selective international markets. Its domestic business covers a summer portfolio (talcum powders including Navratna and Dermicool), hair oils (Kesh King, 7 Oils in One), and a set of 'strategic investments' brands (Axiom/AloFrut juices, IncNut's Vedix and SkinKraft personalised beauty, The Man Company, Brillare) that together account for about 21% of total business. International business sells through distributors in the Middle East, CIS and other geographies; FY26 international sales were disrupted by the Strait of Hormuz closure and ended the year down 5%. Distribution is shifting from traditional wholesale (now ~27% of domestic) toward organised channels (~32%), with quick commerce growing 70% and GT Marts 25% in Q4 FY26. Costs are dominated by other operating expenses at 31.7% of revenue (including advertising, up 12% in Q4), followed by materials at 20.0% and employees at 12.7%; gross margin stood at 69.9% for FY26. FY26 consolidated revenue was INR 3,779.51 crore with an EBITDA margin of 27.48%, and the balance sheet was debt-free with INR 883 crore of net cash. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Summer portfolio (talcum powders — Navratna, Dermicool), Hair oils (Kesh King, 7 Oils in One), Strategic investments portfolio (~21% of business), Other domestic personal care, International business. Brand-led personal care FMCG with seasonal summer exposure and a growing portfolio of acquired digital-first brands.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 3,192 | 3,406 | 3,578 | 3,809 | 3,780 |
| EBITDA (ex other income) | 933 | 863 | 944 | 1,025 | 953 |
| margin % | 29.2 | 25.3 | 26.4 | 26.9 | 25.2 |
| Owners' profit | 839 | 640 | 724 | 806 | 775 |
| EPS, as reported (₹) | 18.88 | 14.50 | 16.55 | 18.48 | 17.76 |
| ROE % · ROCE % | 40.3 · 32.4 | 27.1 · 28.7 | 29.5 · 31.9 | 29.8 · 33.2 | 26.5 · 28.7 |
| Debt / equity (x) | 0.13 | 0.03 | 0.03 | 0.02 | 0.04 |
| Cash from operations | 644 | 749 | 779 | 896 | 801 |
| Capex | (484) | (40) | (41) | (45) | (38) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 891 | 1,049 | 963 | 904 | 799 | 1,152 | 925 | 1,039 |
| Profit before tax | 225 | 306 | 194 | 189 | 152 | 345 | 164 | 196 |
| Net profit | 211 | 279 | 162 | 164 | 148 | 319 | 143 | 139 |
| EPS (₹) | 4.87 | 6.39 | 3.72 | 3.76 | 3.40 | 7.32 | 3.28 | 3.15 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| GODREJ CONSUMER PRODUCTS | 88,507 | 46.2 | 6.99 | 28.7 | 14.7 | 19.0 | 6.6 | 19.8 |
| DABUR INDIA LTD | 66,702 | 33.8 | 5.65 | 22.3 | 15.8 | 19.8 | 6.6 | 24.3 |
| COLGATE PALMOLIVE LTD. | 48,889 | 36.3 | 30.86 | — | 83.7 | 107.1 | — | 31.3 |
| CUPID LIMITED | 37,644 | 102.9 | 83.50 | 249.5 | 24.0 | 30.3 | — | 40.3 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 5 Sept 2026 · Emami promoters report share pledge creation and release | ownership changes | medium | — | — |
| 31 Aug 2026 · Emami 43rd AGM minutes filed, all 8 resolutions passed | compliance | minimal | — | — |
| 29 Aug 2026 · Resignation of Company Secretary & Compliance Officer | management changes | high | — | — |
| 26 Aug 2026 · Emami re-appoints Harsha Vardhan Agarwal as Vice-Chairman and MD for 5 years | management changes | high | — | — |
| 26 Aug 2026 · Emami 43rd AGM: All 8 resolutions passed; some dissent on director reappointments | board shareholder meetings | medium | — | — |
| 25 Aug 2026 · Emami 43rd AGM highlights resilient FY26, acquisitions and Q1 growth | investor communications | medium | — | — |
| 25 Aug 2026 · Emami 43rd AGM held on 25 Aug 2026; 8 ordinary resolutions transacted | board shareholder meetings | low | — | — |
| 12 Aug 2026 · Emami promoters release pledged shares, encumbrance drops to near zero | ownership changes | medium | — | — |
| 10 Aug 2026 · Emami Q1 FY27 call: revenue up 15%, margins under pressure | investor communications | medium | — | — |
| 5 Aug 2026 · Newspaper publication of Q1 FY27 results | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| P&G HYGIENE & HEALTH CARE | 24,410 | 30.9 | 32.40 | — | 113.7 | 134.4 | — | 20.1 |
| GILLETTE INDIA LTD | 23,807 | 35.6 | 25.15 | — | 69.1 | 83.4 | — | 29.8 |
| EMAMI LIMITED ◆ | 15,893 | 21.2 | 5.44 | 15.3 | 26.5 | 28.4 | 5.6 | 23.5 |
| HONASA CONSUMER LIMITED | 15,331 | 52.9 | 10.86 | 48.3 | 14.2 | 16.9 | — | 17.6 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 21.2 | 36.3 | 2 of 15 | 93% |
| P/B | 5.4 | 8.7 | 4 of 13 | 75% |
| ROCE | 28.4 | 19.4 | 7 of 16 | 60% |
| ROE | 26.5 | 15.8 | 4 of 13 | 75% |
| Debt / Equity | 0.0 | 0.0 | 8 of 13 | 42% |
| EBITDA margin | 23.5 | 23.5 | 7 of 13 | 50% |
| Revenue growth | 14.9 | 13.4 | 7 of 14 | 54% |
| Profit growth | (15.4) | 9.4 | 10 of 13 | 25% |
| Market cap | 15893 | 11078 | 7 of 16 | 60% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
